Biologic treatment in combination with lifestyle intervention in moderate to severe plaque psoriasis and concomitant metabolic syndrome: rationale and methodology of the METABOLyx randomized controlled clinical trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Nutrients 13.2021, 9, art. 3015, doi:10.3390/nu13093015, ISSN 2072-6643

Event: Veröffentlichung

(where): Frankfurt am Main

(who): Universitätsbibliothek Johann Christian Senckenberg

(when): 2021

Creator: Pinter, Andreas
Schwarz, Peter
Gerdes, Sascha
Simon, Jan C.
Saalbach, Anja
Rush, James
Melzer, Nima
Kramps, Thomas
Häberle, Benjamin
Reinhardt, Maximilian

URN: urn:nbn:de:hebis:30:3-621818

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pinter, Andreas
Schwarz, Peter
Gerdes, Sascha
Simon, Jan C.
Saalbach, Anja
Rush, James
Melzer, Nima
Kramps, Thomas
Häberle, Benjamin
Reinhardt, Maximilian
Universitätsbibliothek Johann Christian Senckenberg

Time of origin

2021

Other Objects (12)

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Biologic treatment in combination with lifestyle intervention in moderate to severe plaque psoriasis and concomitant metabolic syndrome: rationale and methodology of the METABOLyx randomized controlled clinical trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

Plaque-Psoriasis – Ponesimod zeigt Wirksamkeit

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy

Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis

An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis

Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis

Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis

Related objects

Reset password